Skip to content

Is Naltrexone a Drug? A Comprehensive Guide to its Use in Addiction Treatment

4 min read

Naltrexone is an FDA-approved medication used to treat both alcohol use disorder (AUD) and opioid use disorder (OUD). So, to answer the question, is naltrexone a drug? Yes, it is a non-narcotic, non-addictive prescription medication that plays a crucial role in comprehensive treatment plans.

Quick Summary

Naltrexone is a prescription medication classified as an opioid antagonist. It is used to treat both alcohol and opioid dependence by blocking the euphoric effects of these substances, helping to reduce cravings and prevent relapse.

Key Points

  • A Non-Narcotic Drug: Naltrexone is an FDA-approved prescription drug, but it is not a narcotic or a controlled substance because it is non-addictive.

  • Blocks Effects: It works as an opioid antagonist, binding to opioid receptors to block the euphoric effects of both opioids and alcohol.

  • Treats AUD and OUD: Its primary approved uses are for treating Alcohol Use Disorder (AUD) and Opioid Use Disorder (OUD) as part of a larger treatment plan.

  • Two Formulations: It comes as a daily oral tablet and a once-monthly extended-release injection known as Vivitrol.

  • Opioid-Free Period is Crucial: A person must be free from all opioids for 7 to 14 days before starting naltrexone to avoid severe withdrawal symptoms.

  • Different from Naloxone: Naltrexone is for long-term relapse prevention, whereas naloxone (Narcan) is a fast-acting emergency treatment for opioid overdose.

  • Overdose Risk After Use: Discontinuing naltrexone can lower opioid tolerance, increasing the risk of a fatal overdose if a person relapses.

In This Article

Is Naltrexone a Drug? The Definitive Answer

Yes, naltrexone is unequivocally a drug. Specifically, it is a prescription medication approved by the U.S. Food and Drug Administration (FDA). However, it's crucial to understand its classification. Naltrexone is an opioid antagonist, which means it blocks the effects of opioid drugs; it is not a narcotic, an opioid, or a controlled substance. This distinction is vital: naltrexone does not produce a “high,” is not addictive, and does not cause dependence or withdrawal symptoms upon cessation. It can be prescribed by any practitioner licensed to prescribe medications.

How Does Naltrexone Work?

Naltrexone's mechanism of action involves binding to and blocking opioid receptors in the brain, primarily the mu-opioid receptors. By occupying these sites, it prevents opioids like heroin, morphine, or codeine from producing their characteristic euphoric and sedative effects.

  • For Opioid Use Disorder (OUD): By blocking the receptors, naltrexone prevents a person from feeling the high if they use opioids. This blockade reduces the reinforcing properties of opioid use and can help extinguish the craving and drug-seeking behavior over time. A critical safety measure is that a patient must be completely free of opioids for 7 to 14 days before starting naltrexone to avoid precipitating a sudden and severe withdrawal syndrome.
  • For Alcohol Use Disorder (AUD): The mechanism is slightly different. Alcohol consumption is believed to trigger the release of the body's own endogenous opioids (endorphins), which creates pleasurable feelings. Naltrexone blocks these same receptors, dulling the rewarding effects of alcohol. When the positive reinforcement is removed, the desire to drink often diminishes. Unlike some other medications for AUD, drinking alcohol while on naltrexone does not cause a severe physical sickness; it simply makes the experience less enjoyable.

Naltrexone Formulations: Oral vs. Injectable

Naltrexone is available in two primary forms, offering flexibility for different patient needs:

  • Oral Naltrexone: This form is a tablet (e.g., brand names ReVia, Depade) typically taken daily. Its effectiveness relies heavily on patient adherence to the daily regimen. This can be a challenge, and missed doses can increase the risk of relapse.
  • Injectable Naltrexone (Vivitrol): This is an extended-release formulation administered as an intramuscular injection once a month (every four weeks) by a healthcare professional. Vivitrol solves the problem of daily adherence, ensuring a steady level of the medication in the body for 30 days. This makes it a preferred option for many individuals, particularly those who struggle with maintaining a daily medication schedule.

Naltrexone vs. Naloxone: A Comparison

Though their names are similar, naltrexone and naloxone serve very different purposes. Both are opioid antagonists, but their clinical applications are distinct.

Feature Naltrexone Naloxone (e.g., Narcan)
Primary Use Long-term management and relapse prevention for Opioid Use Disorder and Alcohol Use Disorder. Emergency reversal of an active opioid overdose.
Speed of Action Slow-acting; used for maintenance. Rapid-acting; works within minutes to restore breathing.
Duration of Effect Oral: Effects can last approximately 24 hours. Injectable (Vivitrol): Effects can last approximately 30 days. Short-acting; effects last 30-90 minutes, requiring further medical attention.
Availability Prescription only. Available over-the-counter in many locations.
Purpose To reduce cravings and block euphoric effects over time. To save a life during an overdose event.

Potential Side Effects and Safety Information

While generally well-tolerated, naltrexone can cause side effects. Most are mild and temporary.

Common side effects include:

  • Nausea, vomiting, or abdominal pain
  • Headache
  • Dizziness
  • Fatigue or trouble sleeping
  • Anxiety or nervousness
  • For the injectable form, reactions at the injection site (pain, swelling, redness) can occur.

Important Safety Considerations:

  • Opioid Detoxification: Patients MUST be opioid-free for 7-10 days for short-acting opioids and up to 14 days for long-acting ones before starting naltrexone. Failure to do so can trigger precipitated withdrawal, a rapid and intense onset of withdrawal symptoms.
  • Risk of Overdose: A person on naltrexone may have a reduced tolerance to opioids. If they stop taking naltrexone and relapse, using the same or even a lower dose of opioids they previously used can lead to a fatal overdose. Trying to override the blocking effect by taking large amounts of opioids is also extremely dangerous and can cause serious injury, coma, or death.
  • Liver Health: Naltrexone can affect the liver. It is contraindicated for individuals with acute hepatitis or liver failure. A healthcare provider will typically monitor liver function during treatment.
  • Contraindications: Naltrexone should not be used by individuals who are currently physically dependent on opioids, are in acute opioid withdrawal, have acute hepatitis or severe liver impairment, or have a known hypersensitivity to the drug.

Low-Dose Naltrexone (LDN)

Separate from its use in addiction treatment, very small doses of naltrexone, known as Low-Dose Naltrexone (LDN), are used off-label. LDN is being studied for its potential anti-inflammatory and immune-modulating effects. It has been explored as a treatment for conditions like fibromyalgia, Crohn's disease, multiple sclerosis, and chronic pain. This use is considered experimental and is based on a different mechanism than the higher doses used for AUD and OUD.

Conclusion: Naltrexone's Place in Recovery

So, is naltrexone a drug? Yes, and it is a powerful and valuable one in the field of addiction medicine. As a non-addictive opioid antagonist, it effectively reduces cravings and blocks the rewarding effects of alcohol and opioids, making it an essential tool for preventing relapse. It is not a standalone cure but is most effective when integrated into a comprehensive treatment program that includes counseling, behavioral therapies, and support systems. Whether in its daily oral form or as a monthly injection, naltrexone offers a proven pharmacological pathway to support individuals on their journey toward sustained recovery. For more information, you can visit the Substance Abuse and Mental Health Services Administration (SAMHSA).

Frequently Asked Questions

No. Naltrexone is an opioid antagonist, not a narcotic. It is not classified as a controlled substance by the DEA because it does not cause a 'high' and has no potential for abuse or addiction.

No, you cannot get high on naltrexone. It does not activate opioid receptors; it blocks them. This action prevents the euphoric feelings associated with opioids and alcohol.

To prevent precipitated withdrawal, a patient must be free from short-acting opioids (like heroin or oxycodone) for at least 7 days and long-acting opioids (like methadone) for 10 to 14 days before starting naltrexone.

Unlike some other medications, drinking alcohol on naltrexone will not make you physically ill. Instead, it blocks the pleasurable and rewarding sensations from alcohol, which helps reduce the desire to keep drinking.

Yes, Vivitrol is the brand name for the injectable, extended-release form of naltrexone. It is administered once a month, while generic naltrexone is typically an oral pill taken daily.

Naltrexone is not an opioid and will not cause a positive result on a standard drug screen for opioids. Specific tests for naltrexone exist but are not typically part of routine drug panels.

Naltrexone is a long-term medication used to prevent relapse in alcohol and opioid use disorders. Naloxone (often known by the brand name Narcan) is a fast-acting emergency medication used to reverse an active opioid overdose.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.